Research ArticleClinical Investigations
Subregional Patterns of Preferential Striatal Dopamine Transporter Loss Differ in Parkinson Disease, Progressive Supranuclear Palsy, and Multiple-System Atrophy
Minyoung Oh, Jae Seung Kim, Ji Young Kim, Kwang-Ho Shin, Seol Hoon Park, Hye Ok Kim, Dae Hyuk Moon, Seung Jun Oh, Sun Ju Chung and Chong Sik Lee
Journal of Nuclear Medicine March 2012, 53 (3) 399-406; DOI: https://doi.org/10.2967/jnumed.111.095224
Minyoung Oh
Jae Seung Kim
Ji Young Kim
Kwang-Ho Shin
Seol Hoon Park
Hye Ok Kim
Dae Hyuk Moon
Seung Jun Oh
Sun Ju Chung
Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 53, Issue 3
March 1, 2012
Subregional Patterns of Preferential Striatal Dopamine Transporter Loss Differ in Parkinson Disease, Progressive Supranuclear Palsy, and Multiple-System Atrophy
Minyoung Oh, Jae Seung Kim, Ji Young Kim, Kwang-Ho Shin, Seol Hoon Park, Hye Ok Kim, Dae Hyuk Moon, Seung Jun Oh, Sun Ju Chung, Chong Sik Lee
Journal of Nuclear Medicine Mar 2012, 53 (3) 399-406; DOI: 10.2967/jnumed.111.095224
Subregional Patterns of Preferential Striatal Dopamine Transporter Loss Differ in Parkinson Disease, Progressive Supranuclear Palsy, and Multiple-System Atrophy
Minyoung Oh, Jae Seung Kim, Ji Young Kim, Kwang-Ho Shin, Seol Hoon Park, Hye Ok Kim, Dae Hyuk Moon, Seung Jun Oh, Sun Ju Chung, Chong Sik Lee
Journal of Nuclear Medicine Mar 2012, 53 (3) 399-406; DOI: 10.2967/jnumed.111.095224
Jump to section
Related Articles
Cited By...
- Fast and Accurate Amyloid Brain PET Quantification Without MRI Using Deep Neural Networks
- Association Between White Matter Networks and the Pattern of Striatal Dopamine Depletion in Patients With Parkinson Disease
- Imaging Dopaminergic Neurotransmission in Neurodegenerative Disorders
- Safety of AADC Gene Therapy for Moderately Advanced Parkinson Disease: Three-Year Outcomes From the PD-1101 Trial
- Glucocerebrosidase Mutations and Motor Reserve in Parkinsons Disease
- Clinical and Dopamine Depletion Patterns in Hyposmia- and Dysautonomia-Dominant Parkinsons Disease
- Determining the Degree of Dopaminergic Denervation Based on the Loss of Nigral Hyperintensity on SMWI in Parkinsonism
- Data-driven evolution of neurosurgical gene therapy delivery in Parkinsons disease
- [123I]FP-CIT SPECT in Clinically Uncertain Parkinsonism Predicts Survival: A Data-Driven Analysis
- Association of the Non-Motor Burden with Patterns of Striatal Dopamine Loss in de novo Parkinsons Disease
- Areas of white matter hyperintensities and motor symptoms of Parkinson disease
- Clinical and striatal dopamine transporter predictors of {beta}-amyloid in dementia with Lewy bodies
- Presynaptic Striatal Dopaminergic Function in Atypical Parkinsonism: A Metaanalysis of Imaging Studies
- Levodopa-induced dyskinesia is closely linked to progression of frontal dysfunction in PD
- Effects of dopaminergic depletion and brain atrophy on neuropsychiatric symptoms in de novo Parkinsons disease
- Multiple System Atrophy: An Oligodendroglioneural Synucleinopathy
- Analysis of Extrastriatal 123I-FP-CIT Binding Contributes to the Differential Diagnosis of Parkinsonian Diseases
- Cognitive and Neuroanatomical Correlates in Early Versus Late Onset Parkinsons Disease Dementia
- Is normosmic Parkinson disease a unique clinical phenotype?
- Segmentation-Based MR Attenuation Correction Including Bones Also Affects Quantitation in Brain Studies: An Initial Result of 18F-FP-CIT PET/MR for Patients with Parkinsonism
- Is ioflupane I123 injection diagnostically effective in patients with movement disorders and dementia? Pooled analysis of four clinical trials
- Presynaptic dopamine depletion predicts levodopa-induced dyskinesia in de novo Parkinson disease
- Clinical utility of dopamine transporter single photon emission CT (DaT-SPECT) with (123I) ioflupane in diagnosis of parkinsonian syndromes